Drugs Approved by the FDA

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: Mylan Laboratories
Approval Status: Approved July 1998.
Treatment for: Diabetes Mellitus

General Information

Glyburide tablets in both 1.5 and 3mg strengths have recently been approved to be used as an adjunct to diet to lower the blood glucose level in patients with non-insulin dependent Diabetes Mellitus (Type II), whose Hyperglycemia cannot be controlled by diet alone.